http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020040106-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9634d34eca0d81b5508ed7d63dd155e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate | 2019-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c47d0770329da83ee6e1663ea296684 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_717f12444f042aa7f5a2fcd91e373ea4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64e2bec79f77bbcaad652a5f34e6a5dd |
publicationDate | 2020-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2020040106-A1 |
titleOfInvention | Aβ-PROTEIN-SPECIFIC PRODUCTION INHIBITOR |
abstract | Provided is a compound that specifically inhibits the production of Aβ protein and serves as an active component of a drug for treating and/or preventing Alzheimer's disease. The Aβ-protein-specific production inhibitor according to the present invention is characterized by containing a peptide (FGBTWDYWVYRRR, where B is an L-4,4'-biphenylalanine residue) that comprises an amino acid sequence set forth in SEQ ID NO: 1 and inhibits both β-secretase and γ-secretase activity. A peptide comprising the amino acid sequence set forth in SEQ ID NO: 1 can be utilized in the prevention and/or treatment of Alzheimer's disease. |
priorityDate | 2018-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 146.